Loose bowel motions may be due to an infection (gastroenteritis) but if the symptoms persist for more than 3 weeks then other conditions need to be considered. Sometimes the problem is......

Article

Extended funding for adalimumab (Humira)

Adalimumab is now available for Crohn's disease with fistula formation. This is a severe and disabling complication of Crohn's disease. Often patients with this problem could be funded based on other criteria. However having a complicated or significant fistula is now enough to justify funding for adalimumab. Treatment will need to be for several years as fistulas can be slow to respond

designed and developed by QT Web